Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

3.9K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.9K
Imaging Studies IV: Magnetic Resonance Imaging01:27

Imaging Studies IV: Magnetic Resonance Imaging

188
Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
188

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamic immune profiling predicts response to radiation plus anti-PD-1 therapy in oligometastatic renal cell carcinoma.

Nature communications·2026
Same author

Digital and scalable laser-based fabrication of reusable bismuth telluride thermoelectrics with superior performance and mechanical flexibility.

Npj flexible electronics·2026
Same author

A modified Delphi consensus on tenosynovial giant cell tumour and giant cell tumour of bone : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM).

The bone & joint journal·2026
Same author

Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours : a systematic review and meta-analysis.

Bone & joint open·2026
Same author

Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 study.

The Lancet. Oncology·2026
Same author

Utility of PSMA PET/CT for staging of favourable risk intermediate risk prostate cancer.

European journal of nuclear medicine and molecular imaging·2026

Related Experiment Video

Updated: Dec 23, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

950

Prostate sarcomas: A radiological mimic for benign prostatic hyperplasia.

Thomas Whish-Wilson1,2, Lih-Ming Wong1,2, Shona Hendry3

  • 1Department of Surgery, St Vincent's Hospital Melbourne, 41 Victoria Pde, Fitzroy, Victoria, 3065, Australia.

Urology Case Reports
|April 18, 2020
PubMed
Summary
This summary is machine-generated.

Prostate leiomyosarcomas are rare tumors that can mimic benign prostatic hypertrophy on MRI. Early diagnosis and a treatment approach of neoadjuvant radiotherapy, radical prostatectomy, and lymph node dissection are crucial for effective management.

Keywords:
LeiomyosarcomaMRIProstate cancerSarcoma

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.6K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.9K

Related Experiment Videos

Last Updated: Dec 23, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

950
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.6K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.9K

Area of Science:

  • Urology
  • Oncology
  • Radiology

Background:

  • Prostate leiomyosarcomas are exceptionally rare, comprising only 0.1% of all prostate malignancies.
  • Their low incidence limits the availability of high-level evidence for standardized management protocols.

Observation:

  • A case of prostate leiomyosarcoma is presented that radiologically mimicked benign prostatic hypertrophy on magnetic resonance imaging (MRI).
  • This diagnostic challenge highlights the importance of considering rare differentials in prostate imaging.

Findings:

  • The study emphasizes the critical need for accurate and timely diagnosis of prostate leiomyosarcomas.
  • The described case underscores the potential for misdiagnosis due to imaging similarities with more common conditions.

Implications:

  • We advocate for a neoadjuvant radiotherapy followed by radical prostatectomy with pelvic lymph node dissection treatment strategy.
  • Expedient diagnosis and management are critical for improving outcomes in patients with this rare prostate cancer.